Leprosy in India: The Road to a Disease-Free Future

Leprosy in India is on a promising path towards a disease-free future, thanks to significant advancements like the Multi-Drug Therapy and the National Leprosy Eradication Programme. This matters for UPSC aspirants, especially for GS Papers 2 and 3, focusing on health and social justice. Last Updated: 2025-10-21

Key Facts About Leprosy in India

• Leprosy is a chronic infectious disease caused by Mycobacterium leprae.
• It affects the skin, nerves, eyes, and respiratory tract.
• Over 120 countries are affected, with approximately 200,000 new cases annually.
• 1954: Launch of the National Leprosy Control Programme (NLCP).
• 1983: Transition to the National Leprosy Eradication Programme (NLEP).
• India achieved national leprosy elimination status in 2005.
• Projected national prevalence rate by 2025 is 0.57.
• Child cases among new detections fell from 9.04% to 4.68%.
• New case detection rate dropped from 9.73 to 7.0 per 100,000.
• NSP 2023-2027 aims for transmission interruption by 2030.
• Focus on recovery from COVID-19 impacts and accelerated case detection.
• Nikusth 2.0 Portal launched for patient tracking.
• Integration with health initiatives like Ayushman Bharat.
• Special monitoring in 121 districts with higher prevalence.
• WHO partnership ensures free MDT supply and support.
• Community-based interventions funded by the World Bank.

India's Health and Social Development Goals

Leprosy eradication is crucial for India's broader health and social development goals. Achieving a disease-free status aligns with India's commitment to the Sustainable Development Goals (SDGs), particularly SDG 3, which aims to ensure healthy lives and promote well-being for all. India's efforts in leprosy control also enhance its global standing in public health management, contributing to improved health indices and economic productivity.

Related Government Schemes/Policies

• National Leprosy Eradication Programme (NLEP): Focuses on reducing leprosy prevalence and providing treatment.
• Ayushman Bharat: Provides health coverage and integrates leprosy treatment into broader health services.
• Nikusth 2.0 Portal: A digital platform for tracking leprosy patients and managing cases efficiently.

UPSC Relevance

• GS Paper 2: Health, Government Policies, and Interventions.
• GS Paper 3: Science and Technology, Disease Control.
• Prelims Angle: Questions on disease prevalence, government initiatives, and international collaborations.
• Mains Angle: Analytical themes on public health strategies, disease eradication challenges, and policy effectiveness.

FAQ Section

• What is Leprosy?
  Leprosy is a chronic infectious disease caused by Mycobacterium leprae, affecting the skin, nerves, eyes, and respiratory tract.
• Why is Leprosy important?
  Leprosy control is vital for public health, reducing disability, and achieving India's health goals. It affects over 120 countries globally.
• What are the key features of the National Strategic Plan 2023-2027?
  The NSP aims to interrupt leprosy transmission by 2030, enhance surveillance, and recover from COVID-19 impacts, supported by the Nikusth 2.0 Portal.